Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineering.
Sci Adv
; 9(30): eadd6997, 2023 07 28.
Article
in En
| MEDLINE
| ID: mdl-37494448
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Receptors, Chimeric Antigen
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Sci Adv
Year:
2023
Document type:
Article
Affiliation country:
Estados Unidos